Pan Cancer T

Marconistraat 16

3029 AK Rotterdam

NL

Pan Cancer T

Foundation date

09/09/2020

Sector

#Biotechnology - Therapeutics

Subsector

Pan Cancer T is a biotech spin-out that builds further on 20 years of pioneering in adoptive cell therapy developed in the laboratories of Erasmus MC. We intend to lead the fight against solid cancers through T cell receptor (TCR) gene engineered T-cell therapy. Especially, those solid cancers for which there are limited treatment options and a poor prognosis.

Upcoming events

Latest news

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

  • Innovating today, creating tomorrow: the VIB Bio-Incubator

    Thursday April 18th 2024

  • BioLizard Appoints Matthew Hall as Director of Business Development

    Thursday April 18th 2024